how to get on retatrutide trial with a Clinical Phase-3-Retatrutide-trial-sees-participants-achieve-up-to-30-weight-loss
Description
The cardiovascular markers improved too, with reductions in non-HDL cholesterol and systolic blood pressure that suggest benefits extending well beyond weight management
The more modest increases from 4mg to 8mg to 12mg suggest diminishing returns once the glucagon threshold is crossed
The authors report the fat embolism may have resulted from vascular stasis brought on by shearing injury to the anterior commissure. Thus, the origin of the hemorrhage was presumed to be secondary to accumulation of local microhemorrhages
Metabolic changes In a double-blind, placebo-controlled RCT conducted by Frssing et al
GLP1s could counteract this
